Live Tonight: China's First Approved Domestic Gold-Standard FFR System by BioSensors Life | Artery New Product Showcase Episode 93

Fractional Flow Reserve (FFR) is the gold standard for the precise diagnosis of functional myocardial ischemia caused by coronary artery stenosis. By measuring FFR, physicians can functionally assess whether a stenotic lesion has resulted in functional ischemia and determine the nature and type of the lesion, thereby guiding decisions on stent implantation and selecting the optimal treatment strategy for the patient.

The FFR system independently developed and manufactured by LifeTech Scientific serves asThe first domestically produced FFR system approved as the gold standard, breaking the monopoly of imported products in China.According to updates released by the National Medical Products Administration, this product belongs toInternationally Leading, Domestically Pioneering Products That Fill a Gap in China. This product fills the gap in China’s gold-standard fractional flow reserve (FFR) measurement technology. Moreover, through the innovative design and implementation of pressure microcatheters, it overcomes many of the problems and limitations associated with traditional pressure guidewires, simplifies the clinical FFR measurement workflow, and enhances the ease of use and applicability of interventional FFR measurement techniques.

September 10 (Tuesday) 19:30 VCBeat New Product Review No. 93, featuringWang Lin, Executive Deputy Director of the 8th Ward of the Department of Cardiology, Tianjin Chest Hospital; Huang Benyuan, Domestic Market Product Manager, Northxin LifeTwo guests engaged in a joint discussion to share insights on the innovativeness of LifeTech’s related products.

ByTRUEPHYSIO®Rapid Exchange Pressure MicrocatheterandVivoCardio®Fractional Flow Reserve (FFR) Measurement DeviceComposition

Product Features:

· CathMEMS^®Patented Technology

· Rapid exchange system, compatible with any 0.014'' working guidewire

· Streamlined Design, Ultra-Slim Shaft

· Catheter-Torque Control-Cable: A Tripartite Integrated Design

· Provide a reliable basis for clinical decision-making

Product Features:

· Chinese Touchscreen Control, Easy to Understand and Operate

· Supports Data Recovery Function

· Large-capacity storage space

· Patient Data Protection; Efficient and Convenient Data Access

Wang Lin

M.D., Chief Physician

Ph.D. in Cardiology from Tianjin Medical University, Postdoctoral Fellow at Columbia University Medical Center, currently serving as Executive Deputy Director of the Eighth Ward, Department of Cardiology, Tianjin Chest Hospital.

Graduated from Tianjin Medical University in 2006 with a Ph.D. in Cardiovascular Medicine. Began working in the Department of Cardiology at Tianjin Chest Hospital in the same year. In 2009, completed advanced training in interventional cardiology at Korea University Medical Center. From 2012 to 2013, pursued further specialization in interventional cardiology and intravascular imaging analysis and diagnostic techniques at Columbia University Medical Center (CUMC) and the Cardiovascular Research Foundation (CRF) in the United States.

Possesses extensive experience in the interventional diagnosis and treatment of coronary heart disease, as well as in intracoronary imaging and functional assessment techniques, including Intravascular Ultrasound (IVUS), Optical Coherence Tomography (OCT), and Fractional Flow Reserve (FFR) measurement. Has published numerous professional papers over the years and has served as principal investigator or key participant in multiple research projects.

Huang Benyuan

Product Manager, Domestic Marketing Department, Northcore Life

Shenzhen Northcore Life Technology Co., Ltd. (hereinafter referred to as “Northcore Life”) was established in December 2015 and is headquartered in Shenzhen. Adhering to its mission of improving life and health through innovation and quality, Northcore Life continues to lead in precise cardiovascular interventional solutions. The company has strategically deployed innovative solutions in the fields of coronary artery disease, peripheral vascular disease, and atrial fibrillation. It has obtained more than ten Class III medical device registration certificates. Its commercialized products include the first domestically developed and independently innovated 60 MHz high-definition, high-speed IVUS system to receive approval, the first domestically produced FFR system approved as the gold standard, and vascular access products with leading performance.

NorthLife is China’s first and only national high-tech enterprise to possess a combined portfolio of intravascular functional and imaging products for cardiovascular applications. NorthLife has assembled a team of over 100 outstanding domestic and international research talents and senior industry experts in the medical device sector. The company boasts more than 6,000 square meters of R&D and production facilities, including three GMP-compliant manufacturing workshops. To date, NorthLife holds over 100 patents and has filed more than 200 patent applications. Its independently developed and manufactured products have been adopted by over 1,000 hospitals in China and are exported to numerous countries and regions worldwide, including Belgium, Germany, Italy, and Spain.

NorthCore is committed to building a world-class innovation platform for active interventional medical devices. It has established three core foundational platforms—interventional catheters, micro-nano devices, and high-performance medical electronic software and hardware—driven by technology and guided by market demands. By forging long-term collaborations with leading hospitals in China and renowned cardiovascular experts both domestically and internationally, NorthCore derives sustained momentum for translating cutting-edge scientific technologies and clinical value needs into innovative product development. Dedicated to providing solutions that combine innovation with quality for physicians and patients worldwide, the company strives to become a globally influential medical technology enterprise.

“Artery New Product Showcase” is a live-streaming program designed to support medical enterprises in launching their innovative products. The program’s mission is to facilitate the milestone launch of every innovative medical product. If your company has plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “Artery New Product Showcase,” please add our assistant for consultation.

Scan the QR code below to contact the assistant and schedule a live stream (if already added, please reach out to the assistant directly)

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Send a screenshot of the live stream to the assistant to enter the lucky draw for a chance to win a [15-day trial membership of VBInsight Industry Think Tank].